Tandem Diabetes Care Stock Technical Analysis

TNDM Stock  USD 35.12  0.15  0.43%   
As of the 25th of April, Tandem Diabetes has the Coefficient Of Variation of 777.81, risk adjusted performance of 0.0889, and Semi Deviation of 3.37. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tandem Diabetes Care, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down nineteen technical drivers for Tandem Diabetes Care, which can be compared to its competition. Please validate Tandem Diabetes Care variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Tandem Diabetes is priced more or less accurately, providing market reflects its prevalent price of 35.12 per share. Given that Tandem Diabetes Care has jensen alpha of 0.4113, we advise you to double-check Tandem Diabetes Care's current market performance to make sure the company can sustain itself at a future point.

Tandem Diabetes Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Tandem, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Tandem
  
Tandem Diabetes' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Tandem Diabetes Analyst Consensus

Target PriceAdvice# of Analysts
39.33Buy16Odds
Tandem Diabetes Care current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Tandem analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Tandem stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Tandem Diabetes Care, talking to its executives and customers, or listening to Tandem conference calls.
Tandem Analyst Advice Details
Tandem Diabetes technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Tandem Diabetes technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tandem Diabetes trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Tandem Diabetes Care Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Tandem Diabetes Care volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Tandem Diabetes Care Trend Analysis

Use this graph to draw trend lines for Tandem Diabetes Care. You can use it to identify possible trend reversals for Tandem Diabetes as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Tandem Diabetes price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Tandem Diabetes Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Tandem Diabetes Care applied against its price change over selected period. The best fit line has a slop of   0.22  , which means Tandem Diabetes Care will continue generating value for investors. It has 122 observation points and a regression sum of squares at 1749.73, which is the sum of squared deviations for the predicted Tandem Diabetes price change compared to its average price change.

About Tandem Diabetes Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Tandem Diabetes Care on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Tandem Diabetes Care based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Tandem Diabetes Care price pattern first instead of the macroeconomic environment surrounding Tandem Diabetes Care. By analyzing Tandem Diabetes's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Tandem Diabetes's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Tandem Diabetes specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Payables Turnover11.656.977.664.86
Days Of Inventory On Hand76.61104.47151.69176.39

Tandem Diabetes April 25, 2024 Technical Indicators

Most technical analysis of Tandem help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tandem from various momentum indicators to cycle indicators. When you analyze Tandem charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Tandem Diabetes Care is a strong investment it is important to analyze Tandem Diabetes' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tandem Diabetes' future performance. For an informed investment choice regarding Tandem Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tandem Diabetes Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Tandem Diabetes Care information on this page should be used as a complementary analysis to other Tandem Diabetes' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Tandem Stock analysis

When running Tandem Diabetes' price analysis, check to measure Tandem Diabetes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tandem Diabetes is operating at the current time. Most of Tandem Diabetes' value examination focuses on studying past and present price action to predict the probability of Tandem Diabetes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tandem Diabetes' price. Additionally, you may evaluate how the addition of Tandem Diabetes to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Tandem Diabetes' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tandem Diabetes listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.37)
Earnings Share
(3.43)
Revenue Per Share
11.509
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.1)
The market value of Tandem Diabetes Care is measured differently than its book value, which is the value of Tandem that is recorded on the company's balance sheet. Investors also form their own opinion of Tandem Diabetes' value that differs from its market value or its book value, called intrinsic value, which is Tandem Diabetes' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tandem Diabetes' market value can be influenced by many factors that don't directly affect Tandem Diabetes' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tandem Diabetes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.